Meta description: This regulatory update explains the latest compliance focus for intraaortic balloon counterpulsation trials in adults with cardiogenic shock and the associated sponsor details. Publication time context: 14:57 UTC on February 11, 2026. This article summarizes a regulatory focus on intraaortic balloon counterpulsation compliance in a cardiogenic shock trial. The ClinicalTrials.gov entry for NCT07402018 lists the study conditions as cardiogenic shock; the procedure as intraaortic balloon counterpulsation; and the sponsor as Thomas Jefferson University; recruiting status is indicated. The public record provides a direct link to the study record: https://clinicaltrials.gov/study/NCT07402018?term=medical+device. These details set the context for quality and regulatory teams working on device trials in this space. In this article see quick anchors to key topics below: